Not a good buy right now: price is in a clear downtrend (bearish MAs + weakening MACD), and the latest quarter shows declining revenue and widening losses.
With no Intellectia buy signals today and no positive news catalysts, the risk/reward is skewed against an impatient buyer.
If you already own it, this is more of a “hold/avoid adding” setup near support (~3.48) rather than an aggressive buy.
Trend: Bearish structure (SMA_200 > SMA_20 > SMA_5) suggests the broader trend is down.
Momentum: MACD histogram -0.0258 and negatively expanding → downside momentum is still building.
RSI: RSI_6 = 29.5 (near oversold). This can support a short-term bounce, but it’s not a standalone buy signal in a strong downtrend.
Levels: Current ~3.50 is sitting just above S1 (3.483). A clean break below 3.483 risks a move toward S2 (3.379). Upside resistance starts near Pivot 3.651 then R1 3.819.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Open interest is heavily call-skewed (calls 1207 vs puts 5), but this is likely distorted by extremely low put open interest rather than strong “bullish conviction.”
Options activity today shows effectively no trading volume (todays_volume = 0), limiting how much sentiment can be inferred.
Implied volatility is extremely elevated (30D IV ~173% vs historical vol ~37%), with IV percentile ~92.8 → options market is pricing very large moves (often seen around stress, small caps, or event risk).
Technical Summary
Sell
8
Buy
5
Positive Catalysts
could trigger a short-lived rebound.
Neutral/Negative Catalysts
Strong bearish trend: moving averages and MACD both point to continued downside risk.
Event risk priced in: extremely high implied volatility suggests the market expects sharp movement (not favorable for an impatient, directional long entry without a strong edge).
Fundamental pressure: ongoing losses and revenue contraction reduce confidence in a sustained uptrend.
No supportive news flow in the last week to act as a sentiment/catalyst tailwind.
Financial Performance
Latest quarter: 2026/Q2.
Revenue: $53.20M, down -4.44% YoY → top-line contraction.
Net income: -$4.31M, down -23.71% YoY → losses worsening.
EPS: -$0.34, down -24.44% YoY → negative earnings trend.
Gross margin: 12.62%, up +3.95% YoY → a modest positive (margin improvement), but not enough to offset declining sales and deeper losses.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating trend or price target change data was provided, so the recent Wall Street upgrade/downgrade and target revision picture cannot be confirmed from this dataset.
Pros (what Wall St would likely like, based on provided financials): gross margin improved YoY.
Cons (what Wall St would likely dislike, based on provided financials/price action): revenue down YoY, losses widened, and the stock remains technically bearish—typically a negative setup for upgrades/target raises.
Politicians / influential figures: No recent congress trading data available in the last 90 days (no disclosed buy/sell signal from that source).
Wall Street analysts forecast CULP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CULP is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast CULP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CULP is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
